Material
T he ternary complex factors (TCFs; SAP-1, Elk-1, and Net) are vertebrate Ets domain proteins that link transcription to MAPK signaling, in partnership with the serum response factor (SRF) transcription factor (1) . Relatively little is known about their biological roles in vivo. SAP-1 plays an important role in thymocyte positive selection, the Ras-ERK-dependent process that ensures the survival of cells bearing a productively rearranged TCR (2) (see Refs. 3 and 4 for reviews). In contrast, SAP-1 is not required for negative selection, the ERK-independent process by which thymocytes bearing high self-avidity TCRs are deleted from the T cell repertoire (2, 3) . In contrast, Elk-1 inactivation causes no obvious phenotype, whereas the Net d mutation leads to lymphangiectasia (5, 6) .
Although SAP-1 and Net are highly expressed in the tissues affected by their inactivation (2, 7) , it remains unclear whether the phenotypes result from this as opposed to TCF-specific functions. Although the TCF proteins share many biochemical and functional properties (8, 9) , they differ in DNA-binding specificities (10) , interaction with protein partners (11) , transcriptional activation and repression (9, 12) , and generation of repressive isoforms (1, 8) . SRF target genes specifically recruit TCFs or the myocardin family SRF coactivators, but the basis of this specificity is not understood (13) . Such differences may account for the observation that SAP-1 is not required for b-selection and regulatory T (T reg ) cell development, which are also pre-TCR-or TCR-dependent. In contrast, TCF functional redundancy might explain why the SAP-1 positive-selection defect is mild compared with the strong effect of SRF deficiency (14) (P. Costello, R. Nicolas, and R. Treisman, unpublished observations). Interestingly, previous knockout studies showed that two downstream targets of SAP-1, the zinc finger proteins Egr-1 and Egr-2, are also implicated in positive selection (15) (16) (17) .
In this study, we used the thymocyte system to investigate TCF functional specificity and target gene activation in detail. We show that Elk-1, but not Net, contributes to thymocyte development in SAP-1 2/2 cells and that ectopic expression of Elk-1, but not Net, can rescue the selection defect in SAP-1-deficient cells. Thus, SAP-1 and Elk-1, but not Net, are functionally equivalent in this system. We show that the three TCFs display subtly different target gene specificities in vivo and identify Egr family genes as major targets of TCF signaling in thymocyte development. The ability of ectopically expressed Egr-1 to rescue the thymocyteselection defect in SAP-1 2/2 cells establishes Egr-1, and possibly other members of the Egr family, as the major effector of ERK signaling in thymocyte positive selection.
Materials and Methods
Mice SAP-1 2/2 , Elk-1
2/2
, and Net d animals (2, 5, 6) , kept under specificpathogen-free conditions, were backcrossed to C57/BLJ mice (The Jackson Laboratory, Bar Harbor, ME) for a minimum of five generations and were subsequently crossed with OT-II and HY TCR transgenic mice (2) . Elk-1 is on the X chromosome; for clarity we refer to Elk-1 nulls as Elk-1 2/2 , regardless of gender, and specify gender in the text and figures when appropriate. For reconstitutions, bone marrow from the femurs of 6-wk-old animals or fetal liver cell suspensions from 14.5-d embryos were injected into the tail vein (5 3 10 6 cells/mouse), and analysis was performed 6 wk later. Donor and host cells were distinguished using CD45 alloantigens (donor, CD45.2; host, CD45.1) as described (2) . Animal experimentation, approved by the Cancer Research UK Animal Ethics Committee, was carried out under Home Office License PPL 80/2152.
Flow cytometry
Cells were prepared by gentle disaggregation of tissue through a 70-mm nylon filter using a syringe plunger and stained with saturating concentrations of Ab, as indicated in the figure legends. Analysis was performed on a FACSCalibur (BD Biosciences, San Jose, CA) with CellQuest software. Events were collected and stored ungated in list mode. A MoFlo cell sorter (DakoCytomation, Fort Collins, CO) was used to isolate doublepositive (DP) thymocytes, defined by cell surface marker expression, to $97% purity (FACS analysis). Abs (BD Biosciences CA) were conjugated to FITC, PE, allophycocyanin, or biotin (revealed using streptavidin-TRI-COLOR (Caltag Laboratories, Burlingame, CA) or streptavidinallophycocyanin. Abs (Abs clones in parentheses): CD8 (53-5.8), CD4 (RM4-5), CD69 (H1.2F3), CD3ε (145-2C11), ab TCR (b-chain, H57-597), CD45.1 (A20), CD45.2 (104), va2 TCR (B20.1), HY-TCR (F23.1), CD90.2 (53-2.1), NK1.1 (PK136), and CD49b (DX5). Early T cell progenitor subsets (double negative [DN]1-4) were analyzed for CD44 and CD25 expression by staining with CD25-FITC, CD44-PE, and Thy1.2-allophycocyanin and lineage exclusion of DP, single-positive (SP), and non-T lineage cells using a mixture of biotinylated Abs against CD4, CD8, CD3, B220, Mac-1, NK, Gr-1, and gd. Intracellular TCRb staining was performed as described. Foxp3 intracellular staining was performed using a PE anti-Mouse/Rat Foxp3 staining set (eBioscience, San Diego, CA), according to the manufacturer's instructions. Bone marrow cells and splenocytes were analyzed using B220 (RA3-6B2), IgM (R6-60.2), IgD (11-26c 2a), CD21/CD35 (7G6), and CD23 (B3B4). Progenitor analysis in the bone marrow was performed after RBC lysis as follows: lineage negative gating, StemSep (StemCell Technologies, Vancouver, British Columbia, Canada) and streptavidin Alexa Fluor 750 allophycocyanin; lineage marker staining for c-kit (2B8), Sca-I (D7), CD34 (RAM34), CD16/32 (93), CD127 (A7R34), and CD150 (TC15-12F12.2) (all from eBioscience).
Statistical analysis
The statistical significance of flow cytometric experiments was assessed using the unpaired Student t test, except for the retroviral-reconstitution experiments; because it was unclear whether the data point distribution was Gaussian, we used the nonpaired Mann-Whitney U test.
Cell stimulation
Thymocytes were cultured for 2 h in RPMI 1640 with 10% FCS, 50 mM 2-ME. For stimulation, 10 7 cells were spun (1500 rpm, 5 min) onto anti-CD3-coated six-well plates, washed in PBS, and incubated for 30 min at 37˚C, 10% CO 2 before RNA preparation using GenElute Mammalian Total RNA miniprep columns (Sigma-Aldrich, St. Louis, MO).
Gene-expression analysis
cDNA probes from triplicate total RNA preparations were generated by the Affymetrix GeneChip protocol. Microarray analysis used mouse MOE430 2.0 GeneChips (45,101 probe sets, targeting 42,945 unique refseq mRNA records or 22,640 unique Unigene IDs). Data were preprocessed and quantile normalized using Therma procedure within Bioconductor's Affy package (18) . The group-average expression values were calculated using the relevant (two-way) linear models, and differential genes were selected using an empirical Bayes method implemented in the Bioconductor limma package (18) . A false-discovery rate of 0.05 was used as the cutoff for statistical testing. Microarray data were deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (19) and are accessible through GEO Series accession number GSE21546 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21546).
Target genes were validated using SYBR Green-based real-time PCR (Invitrogen, Carlsbad, CA). Relative abundance of template cDNAwas calculated by the comparative C T (ddC T ) method, normalizing to the abundance of RpS16 cDNA, whose level was invariant under all conditions. Primers for PCR validation of the array data and for TCF mRNA quantitation were as follows: 
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was as described (13), with the following modifications: fixation was stopped by the addition of 250 mM glycine, and sonication was with a Bioruptor UCD 200 (full power, 4 min), with recovery using magnetic protein G beads (Invitrogen). The recovery of DNA was determined by real-time PCR with SYBR Green Invitrogen (11744-500) reagents or Roche Universal Probes and the TaqMan Universal PCR mix (4304437) with the ABI 7900HT PCR machine. Abs used were anti-SRF (sc-335) and SAP-1a (sc-13030; both from Santa Cruz Biotechnology, Santa Cruz, CA), anti-VP16 (V4388; Sigma-Aldrich), and in-house affinity-purified anti-mouse Elk-1 aa309-429, and anti-Net 1995 (20) 15% FCS, 5% WEHI medium supernatant, 5 ng/ml IL-3, 10 ng/ml IL-6, 100 ng/ml stem cell factor [BioSource International, Camarillo, CA]). Then cells were washed and resuspended in 23 prestimulation mixture containing 4 mg/ml polybrene and an equal volume of freshly prepared viral supernatant. Infection was performed by centrifugation at 2000 3 g at room temperature. A second infection was performed 24 h later, and cells were rested 2 h prior to i.v. injection into irradiated hosts. GFP 2 and GFP + thymocyte populations were analyzed 6-8 wk later.
Results
Elk-1 contributes to thymocyte positive selection in SAP-1 null mice Fig. 1 ) (2).
Thymus cellularity was not affected by deletion of Elk-1, but it increased significantly upon deletion of SAP-1 and further increased by additional inactivation of Elk-1 2/2 , reflecting an increase in the absolute numbers of the major thymocyte populations (Fig. 1A) . Total thymocyte numbers also increased upon inactivation of the TCF target gene Egr-1, and this has been attributed to Egr-1-dependent inhibition of progenitor cell entry into the thymus (22) . As previously reported, Elk-1 deletion alone had no effect on the proportion of mature TCR hi thymocytes or the generation of CD4 SP or CD8 SP thymocytes, but SAP-1 inactivation reduced the proportions of these cell types by ∼50% (Fig. 1B-D) (2, 6) . However, in doubly deficient animals, the proportions of CD4 SP and CD8 SP thymocytes, as well as mature TCR hi cells, were reduced by an additional 50% (Fig. 1B-D) . Although this indicates a positiveselection defect, the absolute numbers of SP thymocytes produced was comparable among the different strains, probably reflecting the increased cellularity of the TCF-deficient thymuses (Supplemental Fig. 2A, 2B ). Expression of CD69, a positive-selection marker, was also reduced in SAP-1 null thymocytes and further impaired in SAP-1 2/2 Elk-1 2/2 cells (Supplemental Fig. 2C ). When generated by bone marrow transplant into irradiated B6.SJL hosts, SAP-1 2/2 Elk-1 2/2 thymocytes also exhibited an ∼75% reduction in CD4 SP, CD8 SP, and TCR hi cells, indicating that the selection defect is cell intrinsic (Supplemental Fig. 3 ). The reduced proportions of SAP-1 2/2 Elk-1 2/2 SP thymocytes were retained in chimeric thymuses generated by mixed reconstitution with wildtype (WT) and SAP-1 2/2 Elk-1 2/2 cells; therefore, they do not reflect a reduction in the availability of positively selecting ligands (Fig. 1E ).
To examine the selection of thymocytes bearing a defined TCR, we analyzed OT-II transgenic mice, in which thymocytes bearing TCRa Va2 are selected into the CD4 lineage. Although SAP-1 deletion reduced CD4 SP thymocyte output by 60%, CD4 SP cells were reduced by 90% in two SAP-1 2/2 Elk-1 2/2 primary animals ( 
CD25
2 ) transition, which accompanies rearrangement of the TCR b-chain and assembly of a functional pre-TCR [reviewed in (3, 4) ]; the Egr family of TCF target genes is also implicated in this process (25, 26) . We previously observed no effect on early thymocyte development in SAP-1 null animals (2). SAP-1
-deficient animals also did not display significant perturbation of CD44 + and CD25 + cell populations and showed normal progression through the b-selection checkpoint, as assessed by TCRb expression in CD25 2 cell populations ( Fig. 2C-E) .
B cell lineage-specific inactivation of SRF results in loss of marginal zone B cells and reductions in other B cell types (14 Fig. 6B, 6C ).
The Net d mutation does not affect positive selection
To investigate whether the third TCF, Net, also contributes to immune cell development, we studied mice carrying the Net d mutation, which encodes a truncated Net lacking the Ets domain (5). (Fig. 3B-E) .
All of the genotypes reconstituted thymuses of comparable cellularity, with comparable DN thymocyte profiles and the SAP-1 + CD4 SP thymocytes, which also expressed the T reg cellassociated markers CTLA-4, glucocorticoid-induced tumor necrosis receptor, and CD103, were produced at WT levels (Fig. 3E) . Taken together, these results showed that the intact Net protein is neither required for T reg cell selection nor responsible for the residual positive selection seen in SAP-1 2/2 Elk-1 2/2 animals.
Elk-1, but not Net, can functionally substitute for SAP-1
We next investigated whether ectopic expression of Elk-1 or Net was able to rescue the thymocyte-selection defect in the SAP-1
2/2
OT-II transgenic TCR model discussed above. SAP-1 2/2 OT-II TCR + bone marrow was infected with retroviruses expressing SAP-1, Elk-1, or Net, together with GFP, and used to reconstitute RAG2 2/2 recipient animals ( Fig. 4A, Supplemental Fig. 9 ). In each case, expression of the different TCF mRNAs in the GFP + populations was comparable to that of endogenous SAP-1 mRNA in WT thymocytes; the low level of SAP-1 RNA present in the GFP 2 thymocyte populations presumably reflects their contamination with WT stromal cells from the recipient (Fig. 4A ). Cells transduced with vector alone did not significantly affect CD4 + Va2 hi cell counts in the GFP + thymocyte populations, which were comparable to that observed in radiation chimeras (Fig. 4B, Supplemental  Fig. 4) . In contrast, the SAP-1 retrovirus effectively rescued generation of CD4 + Va2 hi cells in the GFP + population (Fig. 4B,  Supplemental Fig. 9B) . A similar result was obtained with bone marrow transduced with the Elk-1 virus but not the Net virus (Fig.  4B) . We conclude that Elk-1, but not Net, can rescue the positiveselection defect arising from SAP-1 inactivation, provided that it is expressed at an appropriate level.
Target gene induction in TCF knockout animals
We next analyzed the effects of the different TCF mutations on the transcriptional program induced in DP thymocytes following TCR activation. We focused mainly on Elk-1 and SAP-1, because the functional analysis did not indicate a role for Net in thymocyte development. The induced levels of 54 genes were significantly reduced upon deletion of SAP-1, Elk-1, or both; 26 of the genes are known to be SRF targets by functional or ChIP approaches (Table I) (27) . All SAP-1-sensitive genes and the majority of Elk-1-sensitive genes were equally or more severely affected in SAP-1 2/2 Elk-1 2/2 cells (Table I, Supplemental Table I ).
Transcript levels were also confirmed by RT-PCR (Fig. 5A , Supplemental Fig. 8 ). SAP-1 target genes exhibited differential sensitivity to Elk-1 inactivation (Fig. 5A , In the array analysis, SAP-1 inactivation significantly reduced basal transcript levels of only 26 genes, whereas inactivation of Elk-1 affected transcripts corresponding to .600 probe sets. Basal expression of these, together with ∼1000 additional genes, was further impaired in SAP-1 2/2 Elk-1 2/2 cells (Supplemental Table   I ). These results suggest that the Elk-1 TCF may preferentially contribute to basal gene expression in DP thymocytes.
Elk-1 and SAP-1 share genomic targets in WT cells
To assess whether TCF-dependent inducible genes are direct targets for the TCFs, we performed ChIP experiments on unstimulated total thymocytes. SRF was detectable at all of the promoters tested, although the efficiency of recovery varied over a 30-fold range, presumably reflecting differences in cross-linking efficiency and/or binding stoichiometry ( Fig. 5C ; see Discussion). In general, deletion of SAP-1, the principal thymocyte TCF, did not affect SRF recovery, but it did result in a significant decrease in SRF on the Nr4a1 and Ncoa7 genes (see Discussion), whereas deletion of Elk-1 had no substantial effect on SRF recovery. SAP-1 was detectable at each of the promoters tested, and recoveries were reduced to background levels in SAP-1 2/2 cells (Fig.   5C ). In general, SAP-1 recoveries were comparable to those seen with SRF, apart from at the Srf promoter, which responds to signaling predominantly via the myocardin-related transcription factors, which bind SRF competitively with SAP-1 (13). Elk-1 binding to the Egr-1, Egr-2, JunB, and Fos promoters was detected in WT, but not Elk-1 null cells, and it was increased substantially in SAP-1 2/2 cells, suggesting that the two proteins compete for these promoters in WT cells. In contrast, SAP-1 deletion had little or no effect on Elk-1 binding to the Egr-3, Nr4a1, SRF, or Ncoa7 promoters. We also carried out Net ChIP assays, although with this Ab recoveries were more variable. In WT cells, recovery of all promoters was comparable to the background level; SAP-1 and Elk-1 substantially increased recruitment of Net to the Egr-1, The Journal of ImmunologyJunB, and Fos promoters but not to the other promoters tested (Fig. 5C ). Taken together, these results showed that the three different TCFs have subtly different promoter-targeting specificities in vivo (see Discussion).
Ectopic Egr-1 expression can rescue the SAP-1 selection defect
The gene-expression data strongly suggest that Egr family genes, particularly Egr-1 and Egr-2, play an important role in positive selection downstream of ERK-TCF signaling. Previous studies Triplicate RNA preparations from DP thymocytes unstimulated or stimulated for 30 min by plate-bound CD3, from the indicated TCF genotypes, were analyzed. Microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (19) and are accessible through GEO Series accession number GSE21546 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21546). SRF target genes are from previous functional analyses (27) (C. Esnault and R. Treisman, unpublished observations). The Ncoa7 transcripts probably represent the ERK-inducible Ncoa7B transcript (39) , an SRF target (Supplemental Fig. 8B ). showed that inactivation of Egr-1 or Egr-2 can impair positive selection (15) (16) (17) . To test whether Egr family proteins are sufficient to promote positive selection, we tested whether ectopic expression of Egr-1 was able to rescue the thymocyte-selection defect in the SAP-1 2/2 OT-II transgenic TCR model discussed above.
SAP-1 2/2 OT-II TCR + bone marrow was infected with a retrovirus expressing Egr-1 and used to reconstitute RAG2 2/2 recipient animals ( Fig. 4A; Supplemental Fig. 9A ). Cells transduced with the Egr-1 retrovirus effectively rescued generation of CD4 + Va2 hi cells in the GFP + population (Fig. 6) . Thus, Egr family proteins are the major effectors of ERK-SAP-1 signaling in thymocytepositive selection (see Discussion).
Discussion
We investigated differential functionality in immune cell development between members of the TCF family of Ets domain SRF cofactors. The Elk-1 and Net TCFs do not contribute significantly to thymocyte development in the presence of SAP-1. Combination of the SAP-1 null mutation with the Elk-1 null further decreased output of SP thymocytes compared with SAP-1 2/2 cells; however, it did not impair other processes in which ERK signaling has been previously implicated, such as progression through the TCRbrearrangement checkpoint, nor did it result in decreased negative selection in the HY transgenic model. Combination of the Net
mutation with the SAP-1 null had no additional effect on thymocyte development; residual positive selection was observed, even in triply deficient SAP-1
Consistent with these data, ectopic expression of Elk-1, but not Net, restored thymocyte selection in the SAP-1 null OT-II TCR transgenic model. The failure of ectopic Net expression to rescue SAP-1 null phenotypes may reflect differences in its ability to activate genes required for thymocyte development or its weaker potency as an activator (9) . Our data suggest that only SAP-1 and Elk-1 are functionally equivalent in this system and that only the low relative expression level of Elk-1 prevents it and SAP-1 from exhibiting true functional redundancy.
Only a small number of genes exhibit strongly SAP-1-dependent transcription in DP cells, including the Egr-1, Egr-2, and Egr-3 zinc finger proteins; the AP-1 components c-Fos and JunB; and a putative transcriptional coactivator, Ncoa7. Of these, Egr-1 and Egr-2 represent the best candidates for genes required for positive selection, because their activity is most sensitive to SAP-1 deletion, is insensitive to Elk-1 deletion, and is further impaired in SAP-1 thymocytes; however, because functional redundancy exists among at least some Egr family members (28, 29) , it is possible that Egr-2 also contributes to the selection process. Thus, Egr family proteins are the primary effectors of Erk-SAP-1 signaling in thymocyte positive selection. Immediate-early genes are known to exhibit cross-regulation (30, 31) , at least in fibroblasts; therefore, it remains possible that positiveselection defects are also associated with inactivation of c-Fos, JunB, Egr-3, and Ncoa7, although we note that the latter two do not seem to be Elk-1 targets. Because positive selection depends on TCR-induced ERK signaling, TCF target genes affected at the basal level are unlikely to be involved.
Neither SAP-1 nor the other TCFs is required for progress through the b-selection checkpoint. Previous work suggested that b-selection involves Egr family protein function (25, 26) and ERK signaling by the pre-TCR (3). It may be that b-selection requires only basal, TCF-independent levels of Egr proteins and that the ERK signaling requirement reflects induction of their cofactor Nab2 (32) . Egr-1 overexpression in RAG-2 2/2 animals, which cannot generate a pre-TCR or TCR signal, allows thymocyte development only to the intermediate single positive stage (25, 26) , and transgenic expression of a constitutively active SAP-1 variant does so as well (P. Costello, R. Nicolas, and R. Treisman, unpublished observations). Thus, the non-Egr genes involved in b-selection transit are unlikely to be SAP-1 targets. We also observed that thymus size increased as SAP-1 and Elk-1 were progressively inactivated. We speculate that this reflects an increased ability of thymocyte progenitors to enter the thymus, because similar increases are seen upon inactivation of the TCF target gene Egr-1 (15, 22) . Our finding that SAP-1 2/2 Elk-1 2/2 Net d/d thymocytes remain competent for positive selection is surprising considering the severe impairment of positive selection in SRF-deficient animals (P. Costello, R. Nicolas, and R. Treisman, unpublished observations) (14) . Moreover, some aspects of the SAP-1 Elk-1 null phenotype, such as T reg cell selection and reduced peripheral lymphocyte abundance, are reduced rather than enhanced in triply TCF-deficient animals. Net is a weaker transactivator than the other TCFs (9), and RNAs encoding inhibitory isoforms, such as Net-b (8) , are expressed at similar levels to intact Net in thymocytes (Supplemental Fig. 1 ). We suggest that the ability of the Net d mutation to rescue aspects of the SAP-1 Elk-1 null phenotype arises from the ability of other, more active factors to access SRF in the absence of Net. ChIP studies indicated that loss of SAP-1 allows the other TCFs to access at least some SAP-1 target promoters more effectively, and it is possible that in SAP-1 null cells other non-TCF transcription factors also can access TCF target genes required for positive selection. Such factors might be other Ets family proteins, of which many are expressed in any particular cell type (33, 34) and at least some of which can be recruited to DNA by SRF, albeit weakly (35) , or the myocardin-related transcription factors proteins. We cannot exclude the possibility that the truncated polypeptide encoded by Net d (5) retains residual activity, although our functional studies suggest that this is unlikely (C. Esnault and R. Treisman, unpublished observations).
The ability of Elk-1 to rescue the SAP-1 positive-selection phenotype when expressed at an appropriate level suggests that these two TCFs must be able to act through shared targets to promote positive selection. Notwithstanding this, we found that the genetargeting specificities of all of the TCFs are subtly different in vivo. SAP-1, but not Elk-1, is recruited to the Egr-3 and Ncoa7B promoters; therefore, SAP-1 deletion strongly impairs induction of these genes. Net is recruited to only a subset of SAP-1 targets, including Egr-1, c-Fos, and JunB, but not Egr-2 and Egr-3. SAP-1 has a less restricted DNA-binding specificity than Elk-1 (10, 36) , which might partially explain these observations, but Net's in vitro binding specificity has not been assessed. The array data indicated that SAP-1 deletion seems to affect induced transcript levels, whereas Elk-1 deletion predominantly affects basal transcription. Genome-wide analyses strongly implicated Ets family factors in the expression of housekeeping genes through interaction with strong consensus Ets motifs in their promoters (37, 38) . Even if Elk-1 were to preferentially contribute to basal transcription in thymocytes, this is not essential for thymocyte selection, which is insensitive to Elk-1 inactivation.
SAP-1 and Elk-1 are functionally equivalent, at least in the thymus. However, the ChIP data and previous studies (5) showed that Net can also access at least some SAP-1 target genes, suggesting that, in certain contexts, it might also function redundantly with the other TCFs. Given these considerations and the ubiquitous nature of TCF expression, it is surprising that the combination of SAP-1 with other TCF mutations did not significantly broaden the spectrum of phenotypes observed and that even SAP-1 animals, a phenotype also seen upon deletion of SRF in B cells (14) , and the infertility of SAP-1 2/2 Elk-1 2/2 females, a phenotype that probably reflects defective Egr family expression (21) . Our data showed that at least some TCF tissue-or cellspecific phenotypes are a function of a "generic" TCF activity, reflecting the relative expression levels of the functionally equivalent proteins, rather than functional specificity. It will be interesting to probe TCF functional redundancy further by testing whether a particular TCF can fully substitute for another when expressed in situ.
